Table 1.
Characteristics of the patients included and excluded due to lack of liver biopsy.
| Characteristics | Valid patients (n = 155) | Patients without liver biopsy (n = 43) | p |
|---|---|---|---|
| Age, years† | 61 (49–71) | 65 (51–73) | 0.488 |
| Female sex, n (%) | 97 (67) | 23 (54) | 0.280 |
| BMI, Kg/m2† | 28 (26–32) | 28 (24–31) | 0.350 |
| T2DM, n (%) | 30 (19) | 6 (14) | 0.417 |
| Glycemia, mg/dL† | 96 (87–108) | 95 (89–107) | 0.809 |
| HOMA† | 2.7 (1.5–3.98) | 2.6 (1.8–3.9) | 0.586 |
| Triglycerides, mg/dL† | 108 (80–148) | 108 (76–176) | 0.656 |
| Cholesterol, mg/dL† | 192 (172–219) | 187 (164–226) | 0.419 |
| HDL-cholesterol, mg/dL† | 51 (42–59) | 53 (44–63) | 0.547 |
| Metabolic syndrome, n (%) | 103 (67) | 28 (65) | 0.870 |
| ALT, UI/mL† | 18 (14–27) | 19 (15–26) | 0.545 |
| AST, UI/mL† | 18 (16–23) | 18 (15–24) | 0.246 |
| GGT, UI/mL† | 32 (22–62) | 31 (18–56) | 0.510 |
| Liver stiffness, kPa† | 5.1 (4.1–6.6) | 4.8 (4.2–5.3) | 0.279 |
| CAP, dB/m† | 264 (233–308) | 266 (219–327) | 0.485 |
BMI body mass index, T2DM type 2 diabetes mellitus, HOMA homeostasis model assessment.
†Median (Q1-Q3).